The dosimetric leaf gap (DLG) and tongue-and-groove (T&G) effects are critical aspects in the modeling of multileaf collimators (MLC) in the treatment planning system (TPS). In this study, we investigated the dosimetric impact of limitations associated with the T&G modeling in stereotactic plans and its relationship with the need for tuning the DLG in the Eclipse TPS. Measurements were carried out using Varian TrueBeam STx systems from two different institutions. Test fields presenting MLC patterns with several MLC gap sizes (meanGap) and different amounts of T&G effect (TGi) were first evaluated. Secondly, dynamic conformal arc (DCA) and volumetric modulated arc therapy (VMAT) deliveries of stereotactic cases were analyzed in terms of meanGap and TGi. Two DLG values were used in the TPS: the measured DLG (DLG meas ) and an optimal DLG (DLG opt ). Measured and calculated doses were compared according to dose differences and gamma passing rates (GPR) with strict local gamma criteria of 2%/2 mm. The discrepancies were analyzed for DLG meas and DLG opt , and their relationships with both TGi and meanGap were investigated. DCA arcs involved significantly lower TGi and larger meanGap than VMAT arcs (p < 0.0001). By using DLG meas in the TPS, the dose discrepancies increased as TGi increased and meanGap decreased for both test fields and clinical plans. Dose discrepancies dramatically increased with the ratio TGi/meanGap. Adjusting the DLG value was then required to achieve acceptable calculations and configuring the TPS with DLG opt led to an excellent agreement with median GPRs (2%/2 mm) > 99% for both institutions. We also showed that DLG opt could be obtained from the results of the test fields. We demonstrated that the need for tuning the DLG is due to the limitations of the T&G modeling in the Eclipse TPS. A set of sweeping gap tests modified to incorporate T&G effects can be used to determine the optimal DLG value.
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| INTRODUCTION
Stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatments are particularly valuable modalities for treating relatively small lesions with high delivered doses. Stereotactic treatments generally use different delivery techniques: the most popular are dynamic conformal arc (DCA) and volumetric modulated arc therapy (VMAT). Some SBRT protocols, such as RTOG 0236 1 and 0813 2 required a minimum field size, encouraging multiple static beams or DCA. This requirement may be difficult to fulfill with VMAT as multileaf collimator (MLC) apertures do not strictly follow the projection of the planning target volume (PTV). Thus, VMAT arcs may lead to small MLC gaps. Nevertheless, the use of VMAT in SRS and SBRT is becoming increasingly widespread. 3 Since the target volumes are typically small, so are the radiation field sizes involved. This can be challenging for the accuracy of the treatment planning system (TPS) calculations. 4 Hence, the ICRU 91 report 5 recently recommended rigorous testing of the TPS dose calculation accuracy in stereotactic treatments because lesions can be in proximity to vital sensitive structures.
Dose calculation accuracy is known to be affected by inappropriate handling of simplifications in the TPS algorithms and models. [6] [7] [8] For rounded leaf-end MLC systems, the Eclipse TPS requests the user to input two MLC configuration parameters: the MLC transmission ratio and the dosimetric leaf gap (DLG). Some studies 9 have found good agreement between calculated and delivered doses by using the DLG measured with sweeping gap tests 10, 11 or the dynamic chair test. 12 However, other authors [13] [14] [15] found substantial discrepancies and reported on the need for tuning the DLG value configured in the Eclipse TPS. Kielar et al. 13 observed discrepancies between calculated and measured doses around 5% for the Varian's high-definition multileaf collimator (HDMLC), which were greatly reduced by increasing the DLG entered into the TPS by more than 1 mm. Another important characteristic that can affect dose calculation accuracy is the tongue-and-groove (T&G) modeling. Indeed, many MLC models have a T&G design, where the sides of adjacent leaves interlock in order to reduce interleaf transmission. However, this configuration produces underdosage between adjacent leaf pairs in asynchronous MLC movements due to the additional shielding by the tongue of opposing leaf sides during treatment delivery. 16 This underdosage is known as the T&G effect and it can significantly change the dose distribution. 17 In arc treatments, T&G effects are typically smoothed out due to the gantry rotation, but they can produce a reduction in average doses of up to 5%-7%. 18 In a recent study 19 
2.A | MLC model in Eclipse
Only two parameters of the MLC model in Eclipse are user configurable, namely the DLG and the MLC transmission. The TPS uses a single value for MLC transmission, which is the average radiation transmitted through the leaves. Regarding the leaf tip, Eclipse accounts for the increased transmission through the leaf tip by applying a shift to the leaf-end position which amounts to half the DLG value introduced during configuration. Therefore, doses are calculated with an effective gap larger than the nominal gap by a distance equal to the DLG. The procedure recommended by the vendor 11 to determine the DLG is the sweeping gap test as initially introduced by LoSasso et al. 10 For that purpose, the vendor supplies DICOM files implementing the tests that can be readily imported into the TPS. Concerning the modeling of the T&G, Eclipse extends the leaf projections in the direction perpendicular to the leaf motion by a certain tongue width, which is subtracted from the delivered fluence. Thus, the field size in the direction of leaf movements is enlarged by the DLG, while in the perpendicular direction it is reduced due to the tongue width by 0.625 mm. 11, 20 This last value is fixed and unmodifiable by the user.
In this study, two DLG values were assessed: the "measured DLG" (DLG meas ) and the "optimal DLG" (DLG opt 
2.C | Clinical plans
Five SRS brain and five SBRT lung patients were randomly chosen. 
2.C.2 | Analysis of clinical plans and relationship with dose agreement
An in-house software named "Plan-Analyzer," 26 developed in MATLAB ® , was used to parse the MLC information from the DICOM files. In the present study, the meanGap and the mean TGi were investigated. The meanGap for a given arc was calculated as the average leaf pair opening at each control point weighted by the corresponding fractions of MUs. A similar procedure was followed for TGi, which was defined as the ratio of the difference between adjacent leaf positions and their MLC gap, averaged over all the leaves in the beam and all control points. TGi was set to a maximum value of 1 in case of interdigitation (i.e., for s > gap) because the dosimetric impact due to the T&G effect increases linearly with s only for s < gap. 19 The relationships between the dose agreement (in terms of GPR and dose differences at the isocenter) with both meanGap and TGi were investigated. To that aim, results were reported with respect to: (a) meanGap, (b) TGi, and (c) TGi/meanGap. with sweeping gaps without T&G. Nevertheless, as the T&G effect became higher, the discrepancies with DLG meas increased. Some dose differences exceeded 5% and were up to 8% for TGi = 1 and for the smallest gap. In the presence of T&G effects, the agreement clearly improved using DLG opt . With a TGi = 0.25, the dose differences were reduced from 2-4% to nearly 0% and with a higher value of TGi = 0.5 they decreased from 3-6% to 1%. It should be noted that the dose differences for DLG opt were less dependent on the gap size than for DLG meas . Indeed, the curves related to DLG opt for gaps 10, 20, and 30 mm almost overlapped.
Dose differences clearly depended on the ratio TGi/meanGap for DLG meas [ Fig. 1(b) ], with a strong linear behavior (r 2 = 0.883). Discrepancies were larger for the largest ratio, which corresponds to large T&G and small MLC gaps. Tuning the DLG partially compensated for these discrepancies that were noticeably reduced by using DLG opt [see Fig. 1(a) ]. Similar results were obtained for the aSG and aOSG tests in both institutions. Both tests were also carried out for the energies 6 MV FFF, 10 MV FFF, and 10 MV WFF obtaining the same behavior as shown in Fig. 1 , and are provided as Supporting Information in Fig. S1 . The uncertainty U on the ion chamber measurement was estimated to be less than 0.5%.
3.A.2 | Determination of the DLG minΔD
From the results obtained for test fields with DLG meas [ Fig. 1(a) ], the value DLG minΔD that minimizes dose discrepancies between measurements and calculations can be calculated. Let us consider a dose difference ΔD between the measured and calculated doses for an asynchronous sweeping gap field with a particular MLC gap size
"gap" and a representative "TGi": TGi;gap are the calculated doses for a MLC gap of 30 mm and the representative "gap," respectively, corresponding to a particular "TGi." The DLG minΔD value that minimizes dose discrepancies can then be easily obtained as
Using these expressions for TGi = 0.25, a DLG minΔD of 1.0 mm was obtained for the MLC gap widths of 10 and 20 mm, while for TGi = 0.50, the DLG minΔD was 1.2 mm. These values are in agreement with our iteratively derived DLG opt of 1.1 mm.
3.B | Clinical plans
All DCA plans exhibited an excellent agreement for both DLG meas and DLG opt . GPRs (2%/2 mm) were close to 100% for both institutions Table S1 . DLG meas produced excessively low calculated doses and the difference in the dose at the isocenter was reduced from 4% to 1.5% when DLG opt was used [see Fig. 2(b) ]. Results are shown for both the measured DLG and the optimal DLG as a function of (a) TGi and (b) TGi/meanGap.
Boxplots for DCA and VMAT arcs of (a) the GPR (2%/2 mm) and of (b) the dose differences at the isocenter obtained with 1000 SRS for both institutions for 6 MV WFF. Central lines indicate the median value, the box limits represent the 1st and the 3rd quartile and the whiskers indicate the minimum and maximum values (outliers are excluded).
than for lung cases. However, all results were in good agreement for DCA, even for arcs with meanGap ≤ 20 mm. 
| DISCUSSION
The use of VMAT in SBRT and SRS treatments is rapidly increasing 27-29 as a result of its dosimetric advantages over DCA. However, the VMAT technique poses dosimetric challenges such as small MLC apertures, high T&G effects, and individual leaves repeatedly extending into the radiation field. Subsequently, to ensure accurate dose calculation, careful attention should be given to the MLC modeling and to the DLG value used in the Eclipse TPS configuration.
In this study, we showed that configuring Eclipse with DLG meas may lead to large discrepancies between measurements and calculations in VMAT stereotactic plans. Dose differences were nearly 5% on average for VMAT SRS plans with an underestimation of the TPS dose calculations. These discrepancies might have clinically relevant implications and are unacceptable according to international guidelines and QA protocols. [32] [33] [34] It should be noted that good agreement was found for DCA arcs, which present lower T&G effects and larger MLC gaps than VMAT arcs. In DCA, the limited T&G effects were expected since the MLC aperture follows the projection of the PTV with quite uniformly extended leaves. This is not the case for VMAT arcs, where leaves may move back and forth repeatedly thereby increasing T&G effects.
We found that increasing DLG meas in Eclipse by 0.7-0.8 mm greatly reduced discrepancies, producing very good agreement between calculations and measurements (median GPRs > 99%) for VMAT arcs with a stringent local gamma criteria of 2%/2 mm. Eclipse tended to underestimate the calculated dose when DLG meas was used. Increasing the DLG in the TPS increased the calculated doses, consequently improving the agreement between calculations and measurements. This increase in the DLG parameter agrees with findings from other investigators 13, 17, 35 : Kielar et al. 13, 35 increased the value from 0.5 to 1.7 mm and Kim et al. 13, 17, 35 adjusted it from 0.39 to 1.1 mm. Nevertheless, the cause of the discrepancies and the reason to tune the DLG remained unknown to date.
This study investigated the reason why tuning the DLG value was necessary. We demonstrated that dose discrepancies between calculations and measurements were related to limitations in the T&G modeling that could be partially compensated by tuning the DLG. This is, to our knowledge, the first explanation of the need to Both AAA and AXB use the same MLC modeling and thus should suffer from the same limitations regarding the T&G effect and we already showed that they both produced the same differences in the aSG and aOSG tests. 19 Despite that, a better behavior in clinical cases with AXB might be found, because, as presented by Fogliata et al. 36 AXB calculations of small MLC-defined beams output are in better agreement with measurements than AAA and this agreement improves if the DLG is increased.
| CONCLUSIONS
Accurate modeling of the MLC by the TPS is essential, and one of the important aspects is the modeling of the T&G. Calculations for dynamic conformal arcs in SRS and SBRT treatments with the Eclipse TPS are accurate and barely sensitive to the DLG used (DLG meas and DLG opt ) in the TPS configuration. On the contrary, for VMAT Eclipse tended to underestimate the dose and large dose discrepancies were found when DLG meas was used, making it necessary to tune the DLG parameter in order to achieve clinically acceptable calculations.
A clear relation was found between the amount of T&G in the treatment plans and the dose discrepancies when DLG meas was used.
This indicates that the need for tuning the DLG could be due to limitations in the MLC model in the Eclipse TPS, in particular in the modeling of the T&G effect. The aSG and the aOSG tests can be used not only to characterize these limitations, 19 but also to derive the optimal DLG by minimizing dose differences for clinically repre- 
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